TY - JOUR
T1 - Regulation of Low Density Lipoprotein Receptor Function in a Human Hepatoma Cell Line
AU - Leichtner, Alan M.
AU - Krieger, Monty
AU - Schwartz, Alan L.
PY - 1984
Y1 - 1984
N2 - Low density lipoprotein (LDL) processing was investigated in a human hepatoma‐derived cell line, Hep G2. Hep G2 cells bound, internalized and degraded LDL via a saturable, high affinity (Kd ∼ 2 x 10−8 M) pathway similar to that present in other mammalian cells. Although 80% of the uptake and degradation of 125I‐LDL was inhibited by 40‐fold excess native LDL, the same concentration of methylated LDL, which cannot bind to LDL receptors, had virtually no effect on processing. When added at low concentrations, the lysosomotropic agent, chloroquine, inhibited degradation (I50 −15 μM) without affecting the rate of lipoprotein internalization. Receptor activity was decreased 60% by preincubation of the cells in medium containing a source of cholesterol (LDL or unesterified cholesterol) and increased 1.7‐fold by preincubation with com‐pactin, a competitive inhibitor of 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase. The Hep G2 cell line may prove a useful system both for the further study of hepatic lipoprotein metabolism and for the evaluation of new antihypercholesterolemic agents.
AB - Low density lipoprotein (LDL) processing was investigated in a human hepatoma‐derived cell line, Hep G2. Hep G2 cells bound, internalized and degraded LDL via a saturable, high affinity (Kd ∼ 2 x 10−8 M) pathway similar to that present in other mammalian cells. Although 80% of the uptake and degradation of 125I‐LDL was inhibited by 40‐fold excess native LDL, the same concentration of methylated LDL, which cannot bind to LDL receptors, had virtually no effect on processing. When added at low concentrations, the lysosomotropic agent, chloroquine, inhibited degradation (I50 −15 μM) without affecting the rate of lipoprotein internalization. Receptor activity was decreased 60% by preincubation of the cells in medium containing a source of cholesterol (LDL or unesterified cholesterol) and increased 1.7‐fold by preincubation with com‐pactin, a competitive inhibitor of 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase. The Hep G2 cell line may prove a useful system both for the further study of hepatic lipoprotein metabolism and for the evaluation of new antihypercholesterolemic agents.
UR - https://www.scopus.com/pages/publications/84987590222
U2 - 10.1002/hep.1840040638
DO - 10.1002/hep.1840040638
M3 - Article
AN - SCOPUS:84987590222
SN - 0270-9139
VL - 4
SP - 1274
EP - 1278
JO - Hepatology
JF - Hepatology
IS - 6
ER -